Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy

• Published in: Pathology, research and practice research and practice, 2021-11, Vol.227, p.153618-153618, Article 153618
• Main Authors: Mafi, Alireza, Yadegar, Negar, Salami, Marziyeh, Salami, Raziyeh, Vakili, Omid, Aghadavod, Esmat
• Format: Article
• Language: English
• Subjects: Animals; Biomarker; Biomarkers - metabolism; Circular RNAs; Diabetic Nephropathies - diagnosis; Diabetic Nephropathies - genetics; Diabetic Nephropathies - metabolism; Diabetic Nephropathies - therapy; Diabetic nephropathy; Gene Expression Regulation; Genetic Therapy; Humans; Kidney - metabolism; Kidney - pathology; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Predictive Value of Tests; RNA, Circular - genetics; RNA, Circular - metabolism; RNA, Circular - therapeutic use; Signal Transduction; Treatment
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2021.153618

Diabetic nephropathy (DN), also known as diabetic kidney disease (DKD), is a drastic renal complication of type 1 and type 2 diabetes mellitus (DM). Poorly controlled DM over the years, may disrupt kidneys’ blood vessels, leading to the hypertension (HTN) and DN onset. During DN, kidneys’ waste filtering ability becomes disturbed. Being on a healthy lifestyle and controlling both DM and HTN are now the best proceedings to prevent or at least delay DN occurrence. Unfortunately, about one-fourth of diabetic individuals eventually experience the corresponding renal failure, and thus it is critical to discover effective diagnostic biomarkers and therapeutic strategies to combat DN. In the past few years, circular RNAs (circRNAs), as covalently closed endogenous non-coding RNAs (ncRNAs), are believed to affect DN pathogenesis in a positive manner. CircRNAs are able to impact different cellular processes and signaling pathways by targeting biological molecules or various molecular mechanisms. Still, as a key regulatory axis, circRNAs can select miRNAs as their molecular targets, in which they are considered as miRNA sponges. In this way, circRNA-induced suppression of particular miRNAs may prevent from DN progression or promotes the DN elimination. Since the expression of circRNAs has also been reported to be increased in DN-associated cells and tissues, they can be employed as either diagnostic biomarkers or therapeutic targets.